Better than Ritalin: Cogniben for Focus and Attention
10% of children and an estimated 5% of adults suffer from attention disorders (ADHD/ ADD). 41.3% of adults with ADHD can be considered severe. In a recent study, conducted at our clinic, we saw a 43% reduction in moderate-severe ADHD in weeks.
Conventional approaches to ADHD typically involve the use of stimulants (methylphenidate and amphetamine compounds). These treatments can be very effective at improving focus, attention and energy but they also have significant side effects including appetite suppression, insomnia, headache, irritability, weight loss, abdominal pain, nausea.
Amphetamines and methylphenidate are stimulants so it seems contradictory that they can calm a person's brain down. Below is a schematic that illustrates the inhibition of dopamine and serotonin transporters by these medications. The trace amine, β-phenethylamine (PEA) also has this function. The nutritional supplement, Cogniben, contains PEA along with other synergistic ingredients that promote healthy brain levels of cognitive supporting neurotransmitters.
Natural Medicine of Stillwater recently conducted a pilot study that saw an overall reduction of ADHD symptoms by 43%. This was a randomized, single-blind, dose titration, 7-week treatment phase, outpatient study using Cogniben which comprises of synergistic fixed dose combinations of gingko biloba, β-phenethylamine (PEA) and caffeine. Patients "washed out" of prescriptive medication and nutritional supplements before entering the study. Participants were between the ages of 18-55 years old and had no other health issues.
At our clinic we take a holistic approach to mood and cognitive issues and we typically rule out gastrointestinal, neurotransmitter imbalances and genetic predispositions that may factor into a patient's cognitive complaints. At the end of the day, many people are unable to get improved focus and attention without the use of a medication. Cogniben may be a much better solution for those people.